EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?

Ângela Gonçalves iD, Mariana Matias iD, Jorge A R Salvador, Samuel Silvestre iD

International Journal of Molecular Sciences · 27.01.2024 · 25 (3) · 1600

DOI: 10.3390/ijms25031600 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.01.2024. Verfasst von Ângela Gonçalves und 3 weiteren Autor:innen. Beteiligte Einrichtung: CICS-UBI-Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6201-506 Covilhã, Portugal. Hauptthemen laut MEDLINE: Peptic Ulcer, Organometallic Compounds. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 123 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, national funds through the Portuguese Foundation for Science and Technology/MCTES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bismuth compounds are considered relatively non-toxic, with their low solubility in aqueous solutions (e.g., biological fluids) being the major contributing factor to this property. Bismuth derivatives are widely used for the treatment of peptic ulcers, functional dyspepsia, and chronic gastritis. Moreover, the properties of bismuth compounds have also been extensively explored in two main fields of action: antimicrobial and anticancer. Despite the clinical interest of bismuth-based drugs, several side effects have also been reported. In fact, excessive acute ingestion of bismuth, or abuse for an extended period of time, can lead to toxicity. However, evidence has demonstrated that the discontinuation of these compounds usually reverses their toxic effects. Notwithstanding, the continuously growing use of bismuth products suggests that it is indeed part of our environment and our daily lives, which urges a more in-depth review and investigation into its possible undesired activities. Therefore, this review aims to update the pharmaco-toxicological properties of bismuth compounds. A special focus will be given to in vitro, in vivo, and clinical studies exploring their toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptic UlcerOrganometallic CompoundsHumansBismuth

Stichwörter der Autor:innen

bismuth compoundsbismuth iodoform paraffin pastebismuth overusetherapeutic propertiestoxicity

Substanzen

BismuthOrganometallic Compounds

Autor:innen und Institutionen

  • CICS-UBI-Health Sciences Research Centre, University of Beira Interior, Av. Infante D. Henrique, 6201-506 Covilhã, Portugal.
  • Laboratory of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Coimbra, 3000-548 Coimbra, Portugal.
  • CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.

ORCID-Profile: Ângela Gonçalves, Mariana Matias, Samuel Silvestre

Förderung

  • Fundação para a Ciência e Tecnologia
  • national funds through the Portuguese Foundation for Science and Technology/MCTES

Zitieren

APA

Gonçalves, Â., Matias, M., Salvador, J. A. R., & Silvestre, S. (2024). Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?. International Journal of Molecular Sciences, 25(3), 1600. https://doi.org/10.3390/ijms25031600

Vancouver

Gonçalves Â, Matias M, Salvador JAR, Silvestre S. Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?. International Journal of Molecular Sciences. 2024;25(3):1600. doi:10.3390/ijms25031600

BibTeX
@article{Gonalves2024,
  author = {Gonçalves, Ângela and Matias, Mariana and Salvador, Jorge A R and Silvestre, Samuel},
  title = {Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {1600},
  doi = {10.3390/ijms25031600}
}
Kostenlos starten →